Dash Bio
Dash Bio automates clinical bioanalysis to speed drug development and improve assay quality. It combines AI, laboratory robotics, and integrated software to run highly automated, GLP‑compliant labs that support core assays from in vivo studies through late‑stage clinical trials. The platform standardizes workflows and pipelines for pharmacokinetics, biomarker, and assay data, with software integrations that enable end-to-end data flow and reproducible results. Dash Bio operates as a B2B service and software provider for biopharma companies and research laboratories. The company targets scale across preclinical to clinical programs to reduce cycle times and improve the reliability of bioanalytical data.
Dash Bio
Dash Bio automates clinical bioanalysis to speed drug development and improve assay quality. It combines AI, laboratory robotics, and integrated software to run highly automated, GLP‑compliant labs that support core assays from in vivo studies through late‑stage clinical trials. The platform standardizes workflows and pipelines for pharmacokinetics, biomarker, and assay data, with software integrations that enable end-to-end data flow and reproducible results. Dash Bio operates as a B2B service and software provider for biopharma companies and research laboratories. The company targets scale across preclinical to clinical programs to reduce cycle times and improve the reliability of bioanalytical data.
